Zyentia (AggreSolve Technology Platform) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Asset Purch.
  • Financing Rounds
  • 1

Zyentia (AggreSolve Technology Platform) General Information

Description

A silico protein analysis platform. The silico protein analysis platform is used to screen proteins to predict aggregation problems, to predict sequence changes likely to reduce aggregation and to design aggregation inhibitors and stabilizers.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Other Pharmaceuticals and Biotechnology
Acquirer
Primary Office
  • Cambridge
  • England, United Kingdom
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Zyentia (AggreSolve Technology Platform) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Zyentia (AggreSolve Technology Platform)‘s full profile, request access.

Request a free trial

Zyentia (AggreSolve Technology Platform) Executive Team (1)

Name Title Board Seat Contact Info
Jesús Zurdo Founder
To view Zyentia (AggreSolve Technology Platform)’s complete executive team members history, request access »

Zyentia (AggreSolve Technology Platform) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Zyentia (AggreSolve Technology Platform)‘s full profile, request access.

Request a free trial